Lista de obras -

A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus ⬇️

artículo científico publicado el 14 de noviembre de 2012

A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage

artículo científico publicado en 2011

A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania.

artículo científico publicado en 2017

Approaches for Reactive Oxygen Species and Oxidative Stress Quantification in Epilepsy

artículo científico publicado en 2020

Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model

artículo científico publicado en 2018

Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate

artículo científico publicado en 2011

Comparative steady‐state pharmacokinetic evaluation of immediate‐release topiramate and USL255, a once‐daily extended‐release topiramate formulation ⬇️

artículo científico publicado el 20 de mayo de 2013

Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid

artículo científico publicado en 2014

Epilepsy Gene Therapy Using an Engineered Potassium Channel

article

KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy

artículo científico publicado en 2018

Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid

artículo científico publicado en 2015

Pharmacokinetic-Pharmacodynamic Correlation and Brain Penetration of sec-Butylpropylacetamide, a New CNS Drug Possessing Unique Activity against Status Epilepticus.

artículo científico publicado en 2016

Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential

scientific article published on 06 December 2013

Stereoselective pharmacodynamic and pharmacokinetic analysis of sec-Butylpropylacetamide (SPD), a new CNS-active derivative of valproic acid with unique activity against status epilepticus.

artículo científico publicado en 2013

Synthesis and anticonvulsant evaluation of dimethylethanolamine analogues of valproic acid and its tetramethylcyclopropyl analogue

scientific article published on 06 November 2011

Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

artículo científico publicado en 2017

The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus.

artículo científico

Valnoctamide and sec-butyl-propylacetamide (SPD) for acute seizures and status epilepticus.

artículo científico publicado en 2013

Valproic acid derivatives signal for apoptosis and repair in vitro.

artículo científico publicado en 2013

sec-Butyl-propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon-induced status epilepticus in rats.

artículo científico publicado en 2014

Lista de obras de

A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus ⬇️

A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage

A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania.

Approaches for Reactive Oxygen Species and Oxidative Stress Quantification in Epilepsy

Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model

Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate

Comparative steady‐state pharmacokinetic evaluation of immediate‐release topiramate and USL255, a once‐daily extended‐release topiramate formulation ⬇️

Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid

Epilepsy Gene Therapy Using an Engineered Potassium Channel

KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy

Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid

Pharmacokinetic-Pharmacodynamic Correlation and Brain Penetration of sec-Butylpropylacetamide, a New CNS Drug Possessing Unique Activity against Status Epilepticus.

Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential

Stereoselective pharmacodynamic and pharmacokinetic analysis of sec-Butylpropylacetamide (SPD), a new CNS-active derivative of valproic acid with unique activity against status epilepticus.

Synthesis and anticonvulsant evaluation of dimethylethanolamine analogues of valproic acid and its tetramethylcyclopropyl analogue

Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus.

Valnoctamide and sec-butyl-propylacetamide (SPD) for acute seizures and status epilepticus.

Valproic acid derivatives signal for apoptosis and repair in vitro.

sec-Butyl-propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon-induced status epilepticus in rats.